Riboflavin Kinase is a vitamin that is needed for growth and overall good health. It helps the body break down carbohydrates, proteins and fats to produce energy, and it allows oxygen to be used by the body. In enzymology, Riboflavin Kinase is an enzyme that works as catalysis for ATP. Riboflavin is known as Vitamin B2 and is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FMN adenylyltransferase, respectively.
This report aims to provide a comprehensive presentation of the global market for Riboflavin Kinase study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Riboflavin Kinase Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Riboflavin Kinase Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Riboflavin Kinase companies in 2021 (%)
The global Riboflavin Kinase market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Feed Grade Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Riboflavin Kinase include DSM, BASF, NB Group, Shanghai Acebright Pharmaceuticals, Hubei Guangji Pharmaceutical, Ningxia Qiyuan Pharma, Hebei Shengxue Dacheng and Xinfa Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Riboflavin Kinase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Riboflavin Kinase Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Riboflavin Kinase Market Segment Percentages, by Type, 2021 (%)
Feed Grade
Food Grade
Pharma Grade
Global Riboflavin Kinase Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Riboflavin Kinase Market Segment Percentages, by Application, 2021 (%)
Food Additives
Animal Feeding
Pharmaceutical
Health Supplements
Cosmetic And Personal Care
Others
Global Riboflavin Kinase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Riboflavin Kinase Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Riboflavin Kinase revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Riboflavin Kinase revenues share in global market, 2021 (%)
Key companies Riboflavin Kinase sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Riboflavin Kinase sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
DSM
BASF
NB Group
Shanghai Acebright Pharmaceuticals
Hubei Guangji Pharmaceutical
Ningxia Qiyuan Pharma
Hebei Shengxue Dacheng
Xinfa Pharmaceutical
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Riboflavin Kinase Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Riboflavin Kinase Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Riboflavin Kinase Overall Market Size
2.1 Global Riboflavin Kinase Market Size: 2021 VS 2028
2.2 Global Riboflavin Kinase Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Riboflavin Kinase Sales: 2017-2028
3 Company Landscape
3.1 Top Riboflavin Kinase Players in Global Market
3.2 Top Global Riboflavin Kinase Companies Ranked by Revenue
3.3 Global Riboflavin Kinase Revenue by Companies
3.4 Global Riboflavin Kinase Sales by Companies
3.5 Global Riboflavin Kinase Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Riboflavin Kinase Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Riboflavin Kinase Product Type
3.8 Tier 1, Tier 2 and Tier 3 Riboflavin Kinase Players in Global Market
3.8.1 List of Global Tier 1 Riboflavin Kinase Companies
3.8.2 List of Global Tier 2 and Tier 3 Riboflavin Kinase Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Riboflavin Kinase Market Size Markets, 2021 & 2028
4.1.2 Feed Grade
4.1.3 Food Grade
4.1.4 Pharma Grade
4.2 By Type - Global Riboflavin Kinase Revenue & Forecasts
4.2.1 By Type - Global Riboflavin Kinase Revenue, 2017-2022
4.2.2 By Type - Global Riboflavin Kinase Revenue, 2023-2028
4.2.3 By Type - Global Riboflavin Kinase Revenue Market Share, 2017-2028
4.3 By Type - Global Riboflavin Kinase Sales & Forecasts
4.3.1 By Type - Global Riboflavin Kinase Sales, 2017-2022
4.3.2 By Type - Global Riboflavin Kinase Sales, 2023-2028
4.3.3 By Type - Global Riboflavin Kinase Sales Market Share, 2017-2028
4.4 By Type - Global Riboflavin Kinase Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Riboflavin Kinase Market Size, 2021 & 2028
5.1.2 Food Additives
5.1.3 Animal Feeding
5.1.4 Pharmaceutical
5.1.5 Health Supplements
5.1.6 Cosmetic And Personal Care
5.1.7 Others
5.2 By Application - Global Riboflavin Kinase Revenue & Forecasts
5.2.1 By Application - Global Riboflavin Kinase Revenue, 2017-2022
5.2.2 By Application - Global Riboflavin Kinase Revenue, 2023-2028
5.2.3 By Application - Global Riboflavin Kinase Revenue Market Share, 2017-2028
5.3 By Application - Global Riboflavin Kinase Sales & Forecasts
5.3.1 By Application - Global Riboflavin Kinase Sales, 2017-2022
5.3.2 By Application - Global Riboflavin Kinase Sales, 2023-2028
5.3.3 By Application - Global Riboflavin Kinase Sales Market Share, 2017-2028
5.4 By Application - Global Riboflavin Kinase Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Riboflavin Kinase Market Size, 2021 & 2028
6.2 By Region - Global Riboflavin Kinase Revenue & Forecasts
6.2.1 By Region - Global Riboflavin Kinase Revenue, 2017-2022
6.2.2 By Region - Global Riboflavin Kinase Revenue, 2023-2028
6.2.3 By Region - Global Riboflavin Kinase Revenue Market Share, 2017-2028
6.3 By Region - Global Riboflavin Kinase Sales & Forecasts
6.3.1 By Region - Global Riboflavin Kinase Sales, 2017-2022
6.3.2 By Region - Global Riboflavin Kinase Sales, 2023-2028
6.3.3 By Region - Global Riboflavin Kinase Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Riboflavin Kinase Revenue, 2017-2028
6.4.2 By Country - North America Riboflavin Kinase Sales, 2017-2028
6.4.3 US Riboflavin Kinase Market Size, 2017-2028
6.4.4 Canada Riboflavin Kinase Market Size, 2017-2028
6.4.5 Mexico Riboflavin Kinase Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Riboflavin Kinase Revenue, 2017-2028
6.5.2 By Country - Europe Riboflavin Kinase Sales, 2017-2028
6.5.3 Germany Riboflavin Kinase Market Size, 2017-2028
6.5.4 France Riboflavin Kinase Market Size, 2017-2028
6.5.5 U.K. Riboflavin Kinase Market Size, 2017-2028
6.5.6 Italy Riboflavin Kinase Market Size, 2017-2028
6.5.7 Russia Riboflavin Kinase Market Size, 2017-2028
6.5.8 Nordic Countries Riboflavin Kinase Market Size, 2017-2028
6.5.9 Benelux Riboflavin Kinase Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Riboflavin Kinase Revenue, 2017-2028
6.6.2 By Region - Asia Riboflavin Kinase Sales, 2017-2028
6.6.3 China Riboflavin Kinase Market Size, 2017-2028
6.6.4 Japan Riboflavin Kinase Market Size, 2017-2028
6.6.5 South Korea Riboflavin Kinase Market Size, 2017-2028
6.6.6 Southeast Asia Riboflavin Kinase Market Size, 2017-2028
6.6.7 India Riboflavin Kinase Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Riboflavin Kinase Revenue, 2017-2028
6.7.2 By Country - South America Riboflavin Kinase Sales, 2017-2028
6.7.3 Brazil Riboflavin Kinase Market Size, 2017-2028
6.7.4 Argentina Riboflavin Kinase Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Riboflavin Kinase Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Riboflavin Kinase Sales, 2017-2028
6.8.3 Turkey Riboflavin Kinase Market Size, 2017-2028
6.8.4 Israel Riboflavin Kinase Market Size, 2017-2028
6.8.5 Saudi Arabia Riboflavin Kinase Market Size, 2017-2028
6.8.6 UAE Riboflavin Kinase Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 DSM
7.1.1 DSM Corporate Summary
7.1.2 DSM Business Overview
7.1.3 DSM Riboflavin Kinase Major Product Offerings
7.1.4 DSM Riboflavin Kinase Sales and Revenue in Global (2017-2022)
7.1.5 DSM Key News
7.2 BASF
7.2.1 BASF Corporate Summary
7.2.2 BASF Business Overview
7.2.3 BASF Riboflavin Kinase Major Product Offerings
7.2.4 BASF Riboflavin Kinase Sales and Revenue in Global (2017-2022)
7.2.5 BASF Key News
7.3 NB Group
7.3.1 NB Group Corporate Summary
7.3.2 NB Group Business Overview
7.3.3 NB Group Riboflavin Kinase Major Product Offerings
7.3.4 NB Group Riboflavin Kinase Sales and Revenue in Global (2017-2022)
7.3.5 NB Group Key News
7.4 Shanghai Acebright Pharmaceuticals
7.4.1 Shanghai Acebright Pharmaceuticals Corporate Summary
7.4.2 Shanghai Acebright Pharmaceuticals Business Overview
7.4.3 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Major Product Offerings
7.4.4 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Sales and Revenue in Global (2017-2022)
7.4.5 Shanghai Acebright Pharmaceuticals Key News
7.5 Hubei Guangji Pharmaceutical
7.5.1 Hubei Guangji Pharmaceutical Corporate Summary
7.5.2 Hubei Guangji Pharmaceutical Business Overview
7.5.3 Hubei Guangji Pharmaceutical Riboflavin Kinase Major Product Offerings
7.5.4 Hubei Guangji Pharmaceutical Riboflavin Kinase Sales and Revenue in Global (2017-2022)
7.5.5 Hubei Guangji Pharmaceutical Key News
7.6 Ningxia Qiyuan Pharma
7.6.1 Ningxia Qiyuan Pharma Corporate Summary
7.6.2 Ningxia Qiyuan Pharma Business Overview
7.6.3 Ningxia Qiyuan Pharma Riboflavin Kinase Major Product Offerings
7.6.4 Ningxia Qiyuan Pharma Riboflavin Kinase Sales and Revenue in Global (2017-2022)
7.6.5 Ningxia Qiyuan Pharma Key News
7.7 Hebei Shengxue Dacheng
7.7.1 Hebei Shengxue Dacheng Corporate Summary
7.7.2 Hebei Shengxue Dacheng Business Overview
7.7.3 Hebei Shengxue Dacheng Riboflavin Kinase Major Product Offerings
7.7.4 Hebei Shengxue Dacheng Riboflavin Kinase Sales and Revenue in Global (2017-2022)
7.7.5 Hebei Shengxue Dacheng Key News
7.8 Xinfa Pharmaceutical
7.8.1 Xinfa Pharmaceutical Corporate Summary
7.8.2 Xinfa Pharmaceutical Business Overview
7.8.3 Xinfa Pharmaceutical Riboflavin Kinase Major Product Offerings
7.8.4 Xinfa Pharmaceutical Riboflavin Kinase Sales and Revenue in Global (2017-2022)
7.8.5 Xinfa Pharmaceutical Key News
8 Global Riboflavin Kinase Production Capacity, Analysis
8.1 Global Riboflavin Kinase Production Capacity, 2017-2028
8.2 Riboflavin Kinase Production Capacity of Key Manufacturers in Global Market
8.3 Global Riboflavin Kinase Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Riboflavin Kinase Supply Chain Analysis
10.1 Riboflavin Kinase Industry Value Chain
10.2 Riboflavin Kinase Upstream Market
10.3 Riboflavin Kinase Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Riboflavin Kinase Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|